FDA is holding a meeting, launching a pilot, and releasing a concept paper about drug names next month.
Because proprietary lookalike and soundalike drug names have been associated with many drug errors, the Food & Drug Administration is planning to issue a concept paper, launch a pilot program, and hold a public meeting to address this issue. The meeting will be held on June 5 and 6 at the Crowne Plaza Hotel in Silver Spring, Md. The concept paper will be issued before the meeting, which will lay out the logistics of the pilot program. Notice about this meeting was published in the May 12 Federal Register mailing and printing costs for OBNDD. The agency estimates that this new system will eliminate paper, increase efficiency, and save $3,500 in the first year.